Suchergebnisse - (Subject:"2019-nCoV")

PubPharm (695)

1

Third vaccine boosters and anti-S-IgG levels : A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma

enthalten in: The Kaohsiung journal of medical sciences | 2024

von Wang, C. | Huang, C. | Jang, T. | +11

2

Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era : A time-dependent gradient

enthalten in: Vaccine | 2024

von Sukik, L. | Chemaitelly, H. | Ayoub, H. | +21

3

Humoral responses to multiple SARS-CoV-2 variants after two doses of vaccine in kidney transplant patients

enthalten in: Virulence | 2024

von Du, P. | Chang, S. | Ho, T. | +3

4

Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination

enthalten in: Influenza and other respiratory viruses | 2024

von Younes, S. | Nicolai, E. | Pieri, M. | +12

5

Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults : a Nordic cohort study

enthalten in: European heart journal | 2024

von Hviid, A. | Nieminen, T. | Pihlström, N. | +9

6

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients : Single center experience

enthalten in: Medicina clinica | 2024

von Huguet, M. | Boigues, M. | Sorigué, M. | +20

7

COVID-19 vaccines and adverse events of special interest : A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

enthalten in: Vaccine | 2024

von Faksova, K. | Walsh, D. | Jiang, Y. | +32

8

Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines : a nationwide cohort study using an emulated target trial approach

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Choi, M. | Na, Y. | Hyun, H. | +10

9

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination

enthalten in: JAMA network open | 2024

von Gorochov, G. | Ropers, J. | Launay, O. | +32

10

Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years

enthalten in: JAMA network open | 2024

von Hu, M. | Shoaibi, A. | Feng, Y. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[70]